FDA Licenses First At-Home Administered Influenza Vaccine
The U.S. Food and Drug Administration (FDA) has licensed the first of its kind live attenuated nasal spray influenza vaccine that can be administered at home. Adults up to the age 49 will be eligible to self-administer the FluMist Home vaccine or give it to their children two to 17 years old as long as […]
Kindergarten Vaccination Rates Decrease as Vaccine Exemptions Increase
New data released by the U.S. Centers for Disease Control and Prevention (CDC) show that vaccination rates among U.S. kindergartners averaged about 92 percent for the diphtheria, tetanus, and acellular pertussis (DTaP) and measles, mumps and rubella (MMR) vaccines and declined during the 2023-2024 school year, while the percentage of children with vaccine exemptions reached […]
COVID-19 Shots Linked to Higher Incidence of Alzheimer’s Disease
Several studies during the past two years have shown a link between COVID-19 vaccination and the development of neurological complications involving different types of brain dysfunction, including Alzheimer’s disease. The most recent of these studies was published earlier this year in the British medical journal QJM: An International Journal of Medicine. Researchers investigated the association between COVID […]
Florida Health Officials Issue Warning About New mRNA COVID Booster Shots
On Sept. 12, 2024, the Florida Surgeon General and Department of Health provided guidance on 2024/2025 COVID-19 boosters stating that medical providers concerned about the health risks associated with COVID disease for patients over the age of 65 or with underlying health conditions should prioritize patient access to non-mRNA COVID shots and treatment.1 Florida’s Surgeon General Opposes […]
Young Woman With Blood Disorder Develops Painful Severe Reaction to Multiple Vaccinations
A 23-year-old woman being treated for a rare autoimmune blood disorder at UCI Medical Center in Orange, California earlier this month report suffered a severe reaction after receiving multiple vaccines for tetanus, pneumococcal and meningitis at the hospital. Alexis Lorenze, who in January 2024 was diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH), went to UCI Medical […]
Moderna/Merck’s Combo Melanoma Cancer mRNA Therapeutic May Be Ready Next Year
The CEO of Moderna, Inc., Stephane Bancel, said last week that his company may introduce a new mRNA (messenger ribonucleic acid) biologic to treat melanoma cancer as early as 2025. Moderna has been working in partnership with Merck, Inc. to develop a mRNA-based shot that targets skin cancer cells. The product, mRNA-4157 (V940), would be […]